Mutual Funds | ||
Reliance Pharma Fund - Growth |
OVERVIEW | FUND INFO | PORTFOLIO |
Morningstar® Category Sector - Healthcare |
Total Net Assets (mil) 24,202.74 INR |
Morningstar® Benchmark S&P BSE Healthcare PR Used throughout report |
Fund Benchmark S&P BSE Healthcare TR INR |
RETURNS (%) | FUND | BENCHMARK | CATEGORY |
3M | -7.15 | -11.80 | -5.72 |
6M | -5.01 | -7.46 | -2.88 |
1Y | 1.13 | -5.52 | 0.64 |
3Y* | 1.24 | -7.37 | -3.00 |
5Y* | 7.87 | 1.54 | 5.07 |
10Y* | 18.35 | 13.13 | 15.68 |
*Annualised Return | Data Through 18/07/2019 |
QUARTERLY RETURNS (%) | Q1 | Q2 | Q3 | Q4 |
2019 | 1.48 | -6.51 | - | - |
2018 | -7.35 | 6.93 | 10.70 | -5.50 |
2017 | 0.87 | -4.95 | 0.19 | 12.03 |
2016 | -12.47 | 2.17 | 7.77 | -7.22 |
2015 | 9.54 | -2.64 | 14.72 | -2.43 |
RISK MEASURES | |
3Y Alpha | 6.05 |
3Y Beta | 0.81 |
3Y R-Squared | 90.08 |
3Y Info Ratio | 1.36 |
3Y Tracking Error | 5.76 |
3Y Sharpe Ratio | -0.03 |
3Y Std Dev | 14.86 |
3Y Risk | - |
5Y Risk | - |
10Y Risk | - |
Calculations use S&P BSE Healthcare PR (where applicable) |
Morningstar Style BoxTM
![]() |
* Report as of 19 Jul 2019
© 2019 Morningstar. All Rights Reserved.
Disclaimer :
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may
not be copied or redistributed except as specifically authorised;(3) do not constitute investment advice;(4) are provided solely for informational purposes; (5) are not warranted to be complete, accurate or timely; and (6) may
be drawn from fund data published on various dates. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it
and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well
as up.